Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wengler, G.
Right arrow Articles by Parolini, O
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wengler, G.
Right arrow Articles by Parolini, O
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

High prevalence of nonsense, frame shift, and splice-site mutations in 16 patients with full-blown Wiskott-Aldrich syndrome

GS Wengler, LD Notarangelo, S Berardelli, G Pollonni, P Mella, A Fasth, AG Ugazio and O Parolini

Department of Pediatrics, University of Brescia, Italy.

Wiskott-Aldrich syndrome (WAS) is a fully penetrant X-linked recessive disorder characterized by immunodeficiency, thrombocytopenia, and severe eczema. WAS is a life-threatening disease, with a poor quality of life and high mortality rate in childhood. The gene responsible for the disease has been localized to the proximal short arm of the X- chromosome and recently isolated through positional cloning and named WAS protein (WASP). We have characterized 17 WAS families. We have developed a rapid, nonradioactive screening protocol for identifying WASP gene alterations in genomic DNA. Our method allows simultaneous evaluation of single strand confirmation polymorphism and heteroduplex formation. We have identified 15 novel mutations that involve single basepair changes, or small insertions or deletions, all of which result in premature stop cordon, frame shift with secondary premature stop codon, or splice site defect. These studies document the considerable heterogeneity of the location of mutations in the WASP gene causing full-blown WAS and show the efficiency and rapidity of a screening approach for mutation identification in WAS that will be useful for carrier detection and prenatal diagnosis.

Volume 86, Issue 10, pp. 3648-3654, 11/15/1995
Copyright © 1995 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
M. I. Lutskiy, F. S. Rosen, and E. Remold-O'Donnell
Genotype-Proteotype Linkage in the Wiskott-Aldrich Syndrome
J. Immunol., July 15, 2005; 175(2): 1329 - 1336.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Jin, C. Mazza, J. R. Christie, S. Giliani, M. Fiorini, P. Mella, F. Gandellini, D. M. Stewart, Q. Zhu, D. L. Nelson, et al.
Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation
Blood, December 15, 2004; 104(13): 4010 - 4019.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Imai, T. Morio, Y. Zhu, Y. Jin, S. Itoh, M. Kajiwara, J.-i. Yata, S. Mizutani, H. D. Ochs, and S. Nonoyama
Clinical course of patients with WASP gene mutations
Blood, January 15, 2004; 103(2): 456 - 464.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Shcherbina, F. S. Rosen, and E. Remold-O'Donnell
WASP Levels in Platelets and Lymphocytes of Wiskott-Aldrich Syndrome Patients Correlate with Cell Dysfunction
J. Immunol., December 1, 1999; 163(11): 6314 - 6320.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Badolato, S. Sozzani, F. Malacarne, S. Bresciani, M. Fiorini, A. Borsatti, A. Albertini, A. Mantovani, A. G. Ugazio, and L. D. Notarangelo
Monocytes from Wiskott-Aldrich Patients Display Reduced Chemotaxis and Lack of Cell Polarization in Response to Monocyte Chemoattractant Protein-1 and Formyl-Methionyl-Leucyl-Phenylalanine
J. Immunol., July 15, 1998; 161(2): 1026 - 1033.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Petrella, I. Doti, V. Agosti, P. C. Giarrusso, D. Vitale, H.M. Bond, C. Cuomo, P. Tassone, B. Franco, A. Ballabio, et al.
A 5' Regulatory Sequence Containing Two Ets Motifs Controls the Expression of the Wiskott-Aldrich Syndrome Protein (WASP) Gene in Human Hematopoietic Cells
Blood, June 15, 1998; 91(12): 4554 - 4560.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
O. Parolini, G. Ressmann, O. A. Haas, J. Pawlowsky, H. Gadner, W. Knapp, and W. Holter
X-Linked Wiskott-Aldrich Syndrome in a Girl
N. Engl. J. Med., January 29, 1998; 338(5): 291 - 295.
[Full Text] [PDF]


Home page
BloodHome page
F. Candotti, S. A. Oakes, J. A. Johnston, S. Giliani, R. F. Schumacher, P. Mella, M. Fiorini, A. G. Ugazio, R. Badolato, L. D. Notarangelo, et al.
Structural and Functional Basis for JAK3-Deficient Severe Combined Immunodeficiency
Blood, November 15, 1997; 90(10): 3996 - 4003.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Q. Zhu, C. Watanabe, T. Liu, D. Hollenbaugh, R. M. Blaese, S. B. Kanner, A. Aruffo, and H. D. Ochs
Wiskott-Aldrich Syndrome/X-Linked Thrombocytopenia: WASP Gene Mutations, Protein Expression, and Phenotype
Blood, October 1, 1997; 90(7): 2680 - 2689.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. A. Thompson, J. A. Talley, H. N. Do, H. L. Kagan, L. Kunkel, J. Berenson, M. D. Cooper, A. Saxon, and R. Wall
Aberrations of the B-Cell Receptor B29 (CD79b) Gene in Chronic Lymphocytic Leukemia
Blood, August 15, 1997; 90(4): 1387 - 1394.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1995 by American Society of Hematology         Online ISSN: 1528-0020